For immediate release: Friday, November 19, 2021
Boston, MA – A SARS-CoV-2 variant with traits similar to that of the Delta variant—enhanced transmissibility and an ability to infect people who had previous infections/vaccination—will cause a more severe pandemic with more infections and breakthrough infections/reinfections than variants with either trait alone, according to a mathematical model created by researchers at Harvard T.H. Chan School of Public Health.
Their work, which was published online November 19, 2021 in Cell, could help researchers and public health officials interpret the significance of novel and existing variants and design tailored public health responses for various scenarios based on a variant’s characteristics.
“Thus far, evidence of immune escape—the ability of a variant to evade the immune system and cause reinfections or breakthrough infections—has been a red flag,” said Mary Bushman, co-author of the Cell paper and a postdoctoral research fellow in the Department of Epidemiology at Harvard Chan School. “Our findings say it’s maybe more of a yellow flag—this is not such a big deal on its own. But when it’s combined with enhanced transmissibility, then it can be a really big deal.”
As the COVID pandemic has progressed, variants of the initial wild-type SARS-CoV-2 virus have emerged. Some have quickly become a dominant strain and increased the number of infections, like the Alpha and Delta variants, while others, like Beta, failed to take hold or significantly affect the pandemic’s trajectory. To understand the effects that certain factors would have on a pandemic, Bushman created a model that simulates how pandemics fueled by hypothetical variants would affect populations that are using various combinations of masking with physical distancing, and vaccinations.
The analysis simulated a SARS-CoV-2 pandemic with several different hypothetical variants including combinations of the two traits: enhanced transmissibility, similar to the Alpha variant; partial immune escape, similar to the Beta variant; enhanced transmissibility with partial immune escape, similar to the Delta variant; and a variant with neither trait. The analysis also factored in how certain variables, such as masking/physical distancing or vaccinations, would affect the pandemic’s trajectory. For each of the scenarios, the researchers analyzed the total number of infections as well as the number/percentage of infections averted by vaccination.
Bushman and their team determined that a variant with enhanced transmissibility alone would likely be more dangerous than a variant that could partially evade the immune system. Yet a variant with both traits could cause more infections, reinfections, and breakthrough infections than a variant with either trait alone.
According to the model, vaccination is also predicted to be highly beneficial in the case of Delta-like variants because vaccinations would prevent a greater number of cases that a more transmissible virus would potentially cause, and because the milder nature of breakthrough infections should substantially reduce overall mortality.
“It’s really important that people realize the emergence of variants like Delta make high levels of vaccination all the more crucial,” said William Hanage, associate professor of epidemiology and co-author of the Cell paper. “Even if we cannot eliminate the virus, we can ensure that people face it with the best preparation, and a more transmissible virus means there will be more infections in the absence of vaccination, so more people stand to benefit from it.”
This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01AI128344), U.S. National Cancer Institute SeroNet (U01CA261277), and the U.S. Centers for Disease Control and Prevention (200-2016-91779).
“Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape,” Mary Bushman, Rebecca Kahn, Bradford P. Taylor, Marc Lipsitch, William P. Hanage, Cell, online November 19, 2021, doi: 10.1016/j.cell.2021.11.026
For more information:
Harvard T.H. Chan School of Public Health brings together dedicated experts from many disciplines to educate new generations of global health leaders and produce powerful ideas that improve the lives and health of people everywhere. As a community of leading scientists, educators, and students, we work together to take innovative ideas from the laboratory to people’s lives—not only making scientific breakthroughs, but also working to change individual behaviors, public policies, and health care practices. Each year, more than 400 faculty members at Harvard Chan School teach 1,000-plus full-time students from around the world and train thousands more through online and executive education courses. Founded in 1913 as the Harvard-MIT School of Health Officers, the School is recognized as America’s oldest professional training program in public health.